Grail: Downgraded From Speculative Buy To Hold As The Stock Price Appreciated Faster Than Expected [Seeking Alpha]
Exact Sciences Corporation (EXAS)
Last exact sciences corporation earnings: 2/11 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.exactsciences.com/investor-relations/default.aspx
Company Research
Source: Seeking Alpha
GRAL's rally was driven by a Samsung partnership, strong PATHFINDER II trial results, and Abbott's acquisition of Exact Sciences, boosting sector valuations. Business fundamentals are improving with revenue growth, narrowing losses, and a strong cash position, but valuation now reflects much of the upside. Risks at current prices include FDA approval uncertainty, reimbursement challenges, and increased competition, making a Hold rating prudent despite long-term promise. Md Saiful Islam Khan/iStock via Getty Images Introduction When I published this article rating Grail Inc. ( GRAL ) as a Speculative Buy in late September 2025, the stock was trading at around $55 per share, and the company commanded a market capitalization This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of GRAL either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receivin
Show less
Read more
Impact Snapshot
Event Time:
EXAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAS alerts
High impacting Exact Sciences Corporation news events
Weekly update
A roundup of the hottest topics
EXAS
News
- Exact Sciences (NASDAQ:EXAS) was given a new $105.00 price target on by analysts at Stifel Nicolaus.MarketBeat
- Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their RightsPR Newswire
- HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSNPR Newswire
- HAPPY THANKSGIVING AND ALERT: The M&A Class Action Firm Continues to Investigate the Merger – EXAS, SEE, CDTX, and MRSNGlobeNewswire
- Exact Sciences (NASDAQ:EXAS) was downgraded by analysts at TD Cowen from a "strong-buy" rating to a "hold" rating.MarketBeat
EXAS
Earnings
- 11/3/25 - Beat
EXAS
Sec Filings
- 11/26/25 - Form DEFA14A
- 11/24/25 - Form DEFA14A
- 11/21/25 - Form 4
- EXAS's page on the SEC website